International Private Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$510K Sell
21,162
-216
-1% -$5.65K 0.26% 77
2026
Q1
$600K Buy
21,378
+3,117
+17% +$83K 0.37% 61
2025
Q4
$455K Sell
18,261
-107
-0.6% -$2.7K 0.29% 73
2025
Q3
$468K Sell
18,368
-2,312
-11% -$57.1K 0.29% 74
2025
Q2
$501K Buy
20,680
+8,940
+76% +$208K 0.43% 56
2025
Q1
$298K Sell
11,740
-3,442
-23% -$90.1K 0.29% 107
2024
Q4
$403K Buy
15,182
+578
+4% +$15.7K 0.4% 66
2024
Q3
$423K Sell
14,604
-705
-5% -$20.6K 0.62% 40
2024
Q2
$428K Buy
+15,309
New +$421K 0.72% 32

Other funds holding PFE

International Private Wealth Advisors's PFE Position: Q2 2026 in Review

International Private Wealth Advisors reduced its Pfizer (PFE) stake by 1% in Q2 2026, selling an estimated $5.65K and leaving 21,162 shares worth $510K. The position accounts for 0.26% of the portfolio, ranked #77.

International Private Wealth Advisors first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $600K in Q1 2026. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • International Private Wealth Advisors held 21,162 shares of Pfizer worth $510K as of Q2 2026.
  • International Private Wealth Advisors sold 216 Pfizer shares in Q2 2026, an estimated $5.65K.
  • Pfizer made up 0.26% of International Private Wealth Advisors's portfolio in Q2 2026, its #77 holding.
  • International Private Wealth Advisors first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
  • International Private Wealth Advisors's Pfizer position peaked at $600K in Q1 2026.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on International Private Wealth Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.